SIMPARICA DIN 02452049
Status: Marketed
Holder: ZOETIS CANADA INC
Health Canada record
| Active ingredient(s) | SAROLANER 40 MG |
|---|
| Dosage form | Tablet (Chewable) |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 12-Sep-2016 |
|---|
| Current status date | 12-Sep-2016 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SAROLANER
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02482266 | REVOLUTION PLUS | ZOETIS CANADA INC | Solution | SAROLANER 10 MG; SELAMECTIN 60 MG | Marketed |
| 02452030 | SIMPARICA | ZOETIS CANADA INC | Tablet (Chewable) | SAROLANER 20 MG | Marketed |
| 02452057 | SIMPARICA | ZOETIS CANADA INC | Tablet (Chewable) | SAROLANER 80 MG | Marketed |
| 02452065 | SIMPARICA | ZOETIS CANADA INC | Tablet (Chewable) | SAROLANER 120 MG | Marketed |
| 02452014 | SIMPARICA | ZOETIS CANADA INC | Tablet (Chewable) | SAROLANER 5 MG | Marketed |
| 02452022 | SIMPARICA | ZOETIS CANADA INC | Tablet (Chewable) | SAROLANER 10 MG | Marketed |
| 02492652 | SIMPARICA TRIO | ZOETIS CANADA INC | Tablet (Chewable) | SAROLANER 3 MG; MOXIDECTIN 0.06 MG; PYRANTEL (PYRANTEL PAMOATE) 12.5 MG | Marketed |
| 02492660 | SIMPARICA TRIO | ZOETIS CANADA INC | Tablet (Chewable) | SAROLANER 6 MG; MOXIDECTIN 0.12 MG; PYRANTEL (PYRANTEL PAMOATE) 25 MG | Marketed |
| 02492679 | SIMPARICA TRIO | ZOETIS CANADA INC | Tablet (Chewable) | SAROLANER 12 MG; MOXIDECTIN 0.24 MG; PYRANTEL (PYRANTEL PAMOATE) 50 MG | Marketed |
| 02492687 | SIMPARICA TRIO | ZOETIS CANADA INC | Tablet (Chewable) | SAROLANER 24 MG; MOXIDECTIN 0.48 MG; PYRANTEL (PYRANTEL PAMOATE) 100 MG | Marketed |
| 02492695 | SIMPARICA TRIO | ZOETIS CANADA INC | Tablet (Chewable) | SAROLANER 48 MG; MOXIDECTIN 0.96 MG; PYRANTEL (PYRANTEL PAMOATE) 200 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 33637 | 2024-07-16 | Supplement to a New Drug Submission (SNDS) | Additional indication |
| 25654 | 2021-04-13 | Supplement to a New Drug Submission (SNDS) | NEW INDICATION |
| 18734 | 2016-12-06 | Supplement to a New Drug Submission (SNDS) | ADDITIONAL INDICATION |
| 17768 | 2016-02-11 | New Drug Submission (NDS) | |
Request a quote for SIMPARICA
How to read a Canadian DIN record